T H 17 cells (interleukin-17 (IL-17)-producing helper T cells) are highly proinflammatory cells that are critical for clearing extracellular pathogens and for inducing multiple autoimmune diseases 1 . IL-23 has a critical role in stabilizing and reinforcing the T H 17 phenotype by increasing expression of IL-23 receptor (IL-23R) and endowing T H 17 cells with pathogenic effector functions 2, 3 .
However, the precise molecular mechanism by which IL-23 sustains the T H 17 response and induces pathogenic effector functions has not been elucidated. Here we used transcriptional profiling of developing T H 17 cells to construct a model of their signalling network and nominate major nodes that regulate T H 17 development. We identified serum glucocorticoid kinase 1 (SGK1), a serine/ threonine kinase 4 , as an essential node downstream of IL-23 signalling. SGK1 is critical for regulating IL-23R expression and stabilizing the T H 17 cell phenotype by deactivation of mouse Foxo1, a direct repressor of IL-23R expression. SGK1 has been shown to govern Na 1 transport and salt (NaCl) homeostasis in other cells [5] [6] [7] [8] . We show here that a modest increase in salt concentration induces SGK1 expression, promotes IL-23R expression and enhances T H 17 cell differentiation in vitro and in vivo, accelerating the development of autoimmunity. Loss of SGK1 abrogated Na 1 -mediated T H 17 differentiation in an IL-23-dependent manner. These data demonstrate that SGK1 has a critical role in the induction of pathogenic T H 17 cells and provide a molecular insight into a mechanism by which an environmental factor such as a high salt diet triggers T H 17 development and promotes tissue inflammation.
To determine the molecular mechanisms by which naive T cells develop into effector T H 17 cells, we measured genome-wide messenger RNA expression profiles using microarrays along 18 time points over 72 h, following the in vitro exposure of naive T cells to T H 17 polarizing conditions (transforming growth factor b1 (TGF-b1) with IL-6). To examine the role of IL-23 in T H 17 development, we added IL-23 at the late time points (48-72 h) and monitored the transcriptional response in both wild-type and Il23r -/-cells. We ranked the genes according to their extent of induction in cells treated with TGF-b1 and IL-6 (relative to non-polarized activated T cells) and repression in Il23r -/-cells (relative to wild-type cells) (Methods, Fig. 1a and Supplementary Table 1 ). Murine Sgk1 was one of the top ranking genes, whose transcriptional regulation was strongly associated with both IL-23R signalling and T H 17 cell differentiation (Fig. 1a) . Quantitative polymerase chain reaction (qPCR) analysis showed that Sgk1 is induced at low levels by TGF-b1 (induced regulatory T (iT reg ) cells), and not induced in other T cell subsets (T H 0, T H 1, T H 2). As expected, it is most highly expressed under T H 17 differentiation conditions (Fig. 1b) . Sgk1 expression is strongly induced during the first 2 h after stimulation of naive T cells under T H 17-polarizing conditions. This is followed by a sharp decline by 10 h to a steady expression level that is still substantially higher than in the control population ( Fig. 1c and Supplementary  Fig. 1a) . Furthermore, Sgk1 expression is specifically induced and maintained by exposure to IL-23 ( Fig. 1c and Supplementary Fig.  1b) . Although Il23r -/-T cells initially produce Sgk1 mRNA, they cannot sustain this expression ( Supplementary Fig. 1b, c) . Finally, the kinase activity of SGK1 is also significantly higher in T H 17 cells than in other T cell subsets ( Supplementary Fig. 1d ), and restimulation of differentiated T H 17 cells with IL-23 elevates further SGK1 kinase activity ( Supplementary Fig. 1e ). Thus, IL-23 signalling is critical for maintaining Sgk1 expression during T H 17 cell differentiation.
Network analysis of the transcriptional changes in Il23r -/-T cells using the ANAT software 9 singled out SGK1 as a potential nodal point downstream of IL-23R signalling. Based on a curated database of protein-protein interactions (PPIs), we constructed a network model that connects known proteins of the IL-23R signalling pathway (Methods) to the transcription factors whose function is dysregulated in Il23r -/-cells (Methods, Fig. 1d and Supplementary Fig. 1f ). We ranked the network's nodes based on a centrality measure, defined as the fraction of IL-23R-affected transcription factors downstream of that node in the network (Methods and Supplementary Table 1) . SGK1 was the highest-ranking node ( Supplementary Fig. 1g ), suggesting that it acts both as a transcriptional target of IL-23R signalling and as a kinase that may mediate the transcriptional effects of the pathway.
Using Sgk1 -/-mice, we studied the impact of loss of SGK1 on T H 17 differentiation in vitro. We observed no abnormality of SGK1-deficient T cells during primary differentiation into T H 17 cells (Fig. 1e) . However, Sgk1 -/-T H 17 cells restimulated with IL-23 showed impaired IL-17 production ( Fig. 1e and Supplementary Fig. 2b ). Memory Sgk1 -/-T cells also showed a defect in IL-17 production upon IL-23 stimulation, but not under stimulation with TGF-b1 and IL-6 ( Supplementary Fig. 2a) . To study the function of SGK1 specifically in IL-17-producing T cells that carry the CD4 antigen (CD4 1 T cells), we generated Il17f Cre Sgk1 fl/fl mice in which SGK1 was deleted in cells producing IL-17F, enabling us to analyse the function of SGK1 in the maintenance of T H 17 phenotype. Il17f
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fl/fl T cells also showed no defect in primary T H 17 differentiation, but displayed reduced IL-17 production when restimulated with IL-23 ( Fig. 1f and Supplementary  Fig. 2c ). IL-23R expression was also significantly reduced in Sgk1 -/-T cells (Fig. 1g) . Thus, loss of SGK1 does not affect primary T H 17 differentiation, but profoundly affects their stability and IL-23R expression. One possible explanation for the dispensability of SGK1 during primary T H 17 differentiation is redundancy with other kinases, such as its homologue AKT 10 . However, SGK1 seems to be indispensable for IL-23R-dependent stability and maintenance of T H 17 cells.
Microarray analysis of Sgk1 -/-versus wild-type T H 17 cells restimulated with IL-23 showed a significant overlap in differentially expressed genes with the Il23r -/-versus wild-type IL-23-restimulated T H 17 cell profiles, supporting further the functional relatedness of the SGK1 and IL-23R pathways (Fisher exact test, P , 0.001) ( Fig. 1h and Supplementary Fig. 2d ). Consistent with this, genes downregulated in Sgk1 -/-cells are significantly enriched (Fisher exact test, P , 0.001)
for genes that are upregulated in wild-type T H 17 cells compared to other T cell subsets 11 (Methods and Supplementary Fig. 2e ). Selected genes were confirmed by qPCR analysis (Supplementary Fig. 2f ). Genes from several other pathways are also enriched (over-or underexpressed) (Supplementary Table 2 ), including cell cycle and proliferation, which may be related to the known role of SGK1 as a regulator of proliferation and apoptosis 7, 8, 10 . Although our analysis strongly associates SGK1 with the T H 17 program, genes important for development and function of other T cell subsets, such as Ifng, Tbx21 or Gata3 were also dysregulated in Sgk1 -/-cells, suggesting possible additional effects of this kinase in other T cell subsets.
To determine the role of SGK1 in vivo, we immunized Cd4
Cre Sgk1 fl/fl mice with myelin oligodendrocyte glycoprotein (MOG) peptide 35-55 (MOG ) to induce experimental autoimmune encephalomyelitis (EAE). SGK1-deficient mice exhibited significantly reduced EAE incidence and severity. IL-17 production from infiltrated CD4 1 T cells in different organs of SGK1-deficient mice was also reduced, whereas interferon-c (IFN-c) levels were unaffected ( Fig. 2a and Supplementary Fig. 3a) . When we restimulated the isolated T cells from immunized mice with IL-23 in the presence of MOG , the SGK1-deficient T cells also showed impaired IL-17 but normal IFN-c production ( Supplementary Fig. 3b, c) . Next, using Il23r gfp reporter mice, we observed reduced IL-23R-GFP (green fluorescent protein) expression on infiltrating CD4
1 T cells in different organs of SGK1-deficient mice undergoing EAE (Supplementary Fig. 4a ). Similar to the response of Cd4
Cre
Sgk1
fl/fl mice, reduced T H 17 differentiation and disease severity were also observed in Il17f
Cre
Sgk1
fl/fl mice during EAE (Fig. 2b) . In addition, to exclude any effects of SGK1-deficient bystander cells, we transferred purified Il17f
Cre
Sgk1
fl/fl CD4 1 T cells into Rag2 -/-mice and induced EAE. Mice that received SGK1-deficient T cells developed less severe disease compared to mice that received wild-type T cells (Supplementary Fig. 4b ). 
IL-17
1 T cells, we found that 7 and 12 days after transfer, SGK1-deficient T H 17 cells failed to maintain IL-17 production, particularly in the central nervous system (CNS) ( Fig. 2d and Supplementary Fig. 4c ). Next, we crossed Il17f Cre Rosa26R eYFP mice onto the SGK1-deficient background, and analysed the expression of IL-17 in T cells that had turned on the Il17f gene as determined by enhanced yellow fluorescent protein (eYFP) expression. We induced EAE in these mice and analysed the frequency of eYFP 1 cells producing IL-17 in infiltrating CD4 1 T cells in the lymph nodes and CNS. The Sgk1 -/-reporter mice showed a smaller proportion of CD4 1 eYFP 1 T cells in both organs. Furthermore, there was a dramatic loss of IL-17 expression by eYFP 1 T cells in the SGK1-deficient mice, indicating that T H 17 cells could not stably retain IL-17 production during EAE ( Fig. 2e and Supplementary Fig. 4d ).
To understand better the molecular role of SGK1 in T H 17 cells, we conducted another network analysis, using PPI data to connect SGK1 to the transcription factors whose activity is dysregulated in Sgk1 Table 1 and Supplementary Fig. 5a ). Foxo1 phosphorylation by SGK1 in adipocytes has been shown previously to lead to its deactivation and translocation from the nucleus to the cytoplasm 12 . Consistent with this observation, we found that SGK1 phosphorylates Foxo1 (Supplementary Fig. 5b ). Immunoblot analysis of Sgk1 -/-T H 17 cells restimulated with IL-23 confirmed that there is not only reduced phosphorylation of Foxo1 in the nucleus but increased mRNA and protein expression of Foxo1 (Fig. 3b, c) , suggesting that compromised phosphorylation of Foxo1 can result in its own transcriptional upregulation. It has been
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shown previously that Foxo1 can regulate its own expression 13 and we have found that Foxo1 binds to a site located about 1 kilobase (kb) upstream of the first exon in the Foxo1 locus (Supplementary Fig. 6a ).
Transfection of a Foxo1 luciferase reporter in the presence of Foxo1 led to increased luciferase activity ( Supplementary Fig. 6b ), whereas increasing expression of SGK1 in the presence of Foxo1 resulted in a dose-dependent decrease in reporter activity, suggesting that SGK1 inhibited Foxo1-mediated transactivation of its own promoter (Fig. 3d) .
To decipher the consequences of Foxo1 expression on T H 17 cell development, we used Foxo1 -/-CD4 1 memory T cells and observed higher expression of Il23r and Il17a in these cells than in wild-type cells, indicating that Foxo1 may act as a repressor of T H 17 cell development and of IL-23 signalling (Fig. 3e and Supplementary Fig. 6c ). We also found potential binding sites of Foxo1 located about 1 kb upstream of the first exon of the Il23r locus by chromatin immunoprecipitation (ChIP)-PCR ( Supplementary Fig. 6d) (Fig. 3f) . Retinoic-acidreceptor-related orphan receptor ct (RORct) has been suggested to be the master transcription factor of T H 17 development and ChIP-seq 14 (ChIP coupled with high-throughput DNA sequencing) and our ChIP-PCR analysis confirmed that IL-23R is one of the targets of RORct (Supplementary Fig. 6e ). Indeed, we observed that the Il23r promoter is transactivated by RORct in IL-23-restimulated T H 17 cells and it can be inhibited by Foxo1 in a dose-dependent manner ( Supplementary Fig. 6f, g ). While Foxo1 inhibited RORct-mediated Il23r expression, co-expression of SGK1 together with RORct and Foxo1 abrogated the suppressive effects of Foxo1 and rescued Il23r promoter transcriptional activity (Fig. 3g) . Additionally, the inhibition of Il23r transcription by a phosphorylation-insensitive triple alanine mutant of Foxo1, Foxo1 AAA, was not reduced in the presence of SGK1 (Supplementary Fig. 6h ). Furthermore, we observed an endogenous Foxo1-RORct interaction in primary T H 17 cells (Fig. 3h) . These data support a model in which some of the effects of SGK1 are due to phosphorylation of Foxo1, which may be a key step in relieving RORct from Foxo1-mediated inhibition, enhancing the expression of IL-23R.
SGK1 has been reported to act as a mediator for sodium homeostasis. It can be induced by exogenous sodium chloride and is one of the major kinases that regulates Na 1 intake by phosphorylation of epithelial sodium channels (ENaCs) 4, 5 . Considering the defects in T H 17 development in Sgk1 -/-mice, this raised the hypothesis that increasing sodium concentration may affect the T H 17 cell phenotype through SGK1. To test this, we first activated naive T cells in the presence of additional NaCl, but in the absence of any polarizing cytokines. Microarray analysis of these NaCl-treated cells showed a significant upregulation of Sgk1 and of multiple other genes associated with T H 17 development (Fisher exact test; P , 0.001; Supplementary Table 2 and Supplementary Fig. 7a ), which we confirmed by qPCR analysis of selected genes (Supplementary Fig. 7b ). We also found increased mRNA and protein levels of IL-17 and IL-23R with additional NaCl under various T H 17 polarizing conditions (Fig. 4a, b and Supplementary Fig. 7c ). Furthermore, a sodium-induced increase in T H 17 development and IL-23R expression was not observed in SGK1-deficient T cells, specifically in the context of IL-23-IL-23R signalling (Fig. 4c, d) . Importantly, culturing cells with mannitol did not alter T H 17 cell differentiation, excluding the possibility that the T H 17 program is initiated simply by the alteration of osmotic pressure ( Supplementary Fig. 7d ). 
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Recent studies have shown that different components in the daily diet and gut microbiota can strongly affect the frequency of effector T cells in the gut 15, 16 . Furthmore, previous data indicate that molecules related to sodium homeostasis can influence T H 17 cell responses 17, 18 . To understand further the effect of NaCl on T H 17 cell generation in vivo, we fed a high salt diet (HSD) to wild-type or Cd4
Cre Sgk1 fl/fl mice. After 3 weeks on HSD, we observed that un-immunized wildtype mice showed a marked increase in the frequency of T H 17 cells in the lamina propria, whereas no notable changes were observed in the mesenteric lymph nodes or spleen. Conversely, SGK1-deficient mice 
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showed a much milder enhancement of T H 17 cell frequency in the gut, whereas there was no increase in IFN-c production in any of the mice fed with HSD ( Supplementary Fig. 8a, b) .
Finally, we studied whether HSD would affect the development of T H 17 and EAE in vivo. Wild-type mice fed HSD had more severe EAE than mice fed a normal diet, and this increased severity was dramatically reduced in SGK1-deficient mice ( Fig. 4e and Supplementary Fig.  8c,d) . We also observed a significantly higher frequency of T H 17 cells in mesenteric lymph nodes and CNS of wild-type mice fed with HSD than in those of SGK1-deficient mice fed with HSD. The percentage of IFN-c producing T cells in the CNS, but not in the peripheral immune compartments, of wild-type mice was increased in mice fed HSD, suggesting that HSD may increase infiltration but not expansion of IFN-c 1 effector T cells in the target organs ( Fig. 4f and Supplementary  Fig. 8e ). Consistent with our in vitro data, we observed elevated IL-17 but not IFN-c production from CD4 1 T cells isolated from EAEimmunized wild-type mice fed with HSD and restimulated in vitro with MOG 35-55 , compared to production from cells from EAE mice fed a normal diet (Supplementary Fig. 8f ). The data presented here indicate that high sodium intake potentiates T H 17 cell generation in vivo in an SGK1-dependent manner and therefore has the potential to increase the risk of promoting autoimmunity.
In conclusion, we used a combination of microarray data analysis, large-scale PPI network analysis and experimental data from several different knockout mice to establish IL-23R-SGK1-Foxo1 as a critical axis in T H 17 stabilization. We show that Foxo1 acts as a repressor of IL-23R expression by binding directly to the Il23r promoter and inhibiting RORct-mediated Il23r transactivation. Phosphorylation of Foxo1, mediated by SGK1, leads to its deactivation and promotes unopposed RORct-mediated Il23r transcription. SGK1 has been studied extensively in the context of NaCl transport 19, 20 . Modest increase of the NaCl concentration induces SGK1 expression in T cells with increased IL-23R expression and T H 17 cell generation in vitro. Interestingly, even in un-immunized mice fed with HSD, enhancement of T H 17 differentiation was observed in vivo in the gut and gut-associated lymphoid tissue, and this increase in T H 17 cells can be recalled at other peripheral sites after immunization. Although our data suggest an essential role for SGK1 in this process, it is likely that other immune cells and pathways are also influenced by increased salt intake. Furthermore, our results do not exclude additional alternative mechanisms by which an increase in NaCl affects T H 17 cells. Nevertheless, the elevated in vivo T H 17 differentiation resulting from HSD raises the important issue of whether increased salt in westernized diets and in processed foods contributes to an increased generation of pathogenic T H 17 cells and for an unprecedented increase in autoimmune diseases.
METHODS SUMMARY
Microarrays and network analysis. For gene-expression analysis Affymetrix microarray chips were used. Data were processed using the GenePattern suite 21 . Differentially expressed genes were detected using fold-change and t-test analysis (for Sgk1 -/-and NaCl-treated T cells) or a consensus of fold-change, the EDGE software 22 and a novel sigmoid-based method 23 (for the Il23r -/-T H 17 cell time-course data). A command-line version of the ANAT software 9 was used for network analysis. In vitro T cell differentiation. Naive T cells were FACS-sorted, stimulated with plate-bound anti-CD3 and anti-CD28 antibodies and the indicated cytokines or NaCl, and cells were analysed by qPCR or flow cytometry at different time points. Experimental autoimmune encephalomyelitis model. Mice were immunized subcutaneously with MOG 35-55 in complete Freud's adjuvant (CFA), and heatinactivated Mycobacterium tuberculosis and with intraperitoneal injection of Bordatella pertussis toxin. In vivo cell transfer. Naive T cells were differentiated towards T H 17 cells, then transferred into MOG 35-55 -CFA-immunized hosts and T cells isolated from various organs were analysed by flow cytometry at 7-12 days after onset of EAE. Western blot and immunoprecipitation. Differentiated T cells or transfected HEK293T cells were lysed in whole cell extract (WCE) buffer (containing 50 mM Tris buffer, pH 7.5, 100 mM NaCl, 0.1% Triton X-100, 10% v/v glycerol, 1 mM DTT, 1 mM PMSF and protease inhibitors (Sigma)), and lysates were subjected to western blot or immunoprecipitation analysis.
Promoter-activity reporter assay. HEK293T cells were transfected with luciferase reporter constructs and expression vectors, and luciferase expression was determined after 48 h.
